No profile data available.
Oncology Pharma Inc. (ONPH) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in San Francisco, United States.
It reported revenue of $1.18 million for fiscal year 2004, down 64.0% from fiscal year 2003, and net income of -$1.57 million. In Q3 2005 (the quarter ended December 31, 2004) revenue was $0, down 100.0% from a year before. Its market capitalization was $4.11 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2004; market data as of October 9, 2026.
, an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc.
Oncology Pharma reported $1.18 million in revenue for fiscal year 2004, down 64.0% from $3.28 million in fiscal year 2003. In Q3 2005 revenue was $0.
$4.11 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Can-Fite BioPharma Ltd. (CANF), LianBio (LIANY), Intellipharmaceutics International Inc. (IPCIQ), Acusphere, Inc. (ACUS).